AstraZeneca’s oral GLP-1 advances to Phase III after strong trial results

AstraZeneca’s oral GLP-1 advances to Phase III after strong trial results

Investing.com–AstraZeneca PLC (LON:) is advancing its oral GLP-1 receptor agonist elecoglipron into a Phase III clinical program after two mid-stage trials demonstrated meaningful weight loss and blood sugar reduction. Shares in the company rose 0.7% in after-hours trade.  According to data from the VISTA Phase IIb trial, adults with obesity or who were overweight receiving…

Read Full News
Pope Leo XIV advances sainthood causes, including Dutch nun who served in Missouri

Pope Leo XIV advances sainthood causes, including Dutch nun who served in Missouri

Pope Leo XIV issued decrees advancing the sainthood causes of five candidates, including a Dutch nun who served in St. Louis in the early 20th century. During a meeting April 27, with Cardinal Marcello Semeraro, prefect of the Dicastery for the Causes of Saints, the pope signed a decree recognizing the heroic virtues of Carmelite Sr. Teresia of the…

Read Full News
Uzbekistan advances NSDI project with EU and World Bank support

Uzbekistan advances NSDI project with EU and World Bank support

Shorouk Express TASHKENT, Uzbekistan, June 27. Uzbekistan, the European Union, and the World Bank have held a meeting to explore future cooperation within the framework of the National Spatial Data Infrastructure (NSDI)project, Trend reports. The meeting brought together Ilkhom Norkulov, First Deputy Minister of Economy and Finance of the Republic of Uzbekistan; Jana Kurpiša, representative…

Read Full News